Representative before the EPO

Technology company logo thumb
no operation time available
Technology Company

Julien Schirlin has worked on the following 52 EPO patent applications which have been published in the last five years:

EP10795311

1, 7 - DIAZACARBAZOLES AND THEIR USE IN THE TREATMENT OF CANCER

IPC classification:
A61K 31/4427, A61P 35/00, C07D 471/14
Applicant:
F. Hoffmann-La Roche AG
Agent:
Julien Schirlin, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP11713749

PYRAZOL-4-YL-HETEROCYCLYL-CARBOXAMIDE COMPOUNDS AND METHODS OF USE

IPC classification:
A61K 31/4155, A61P 35/00, C07D 401/12, C07D 401/14, C07D 403/12, C07D 403/14, C07D 417/12, C07D 417/14
Applicant:
F. Hoffmann-La Roche AG
Agent:
Julien Schirlin, F. Hoffmann-La Roche AG
Status:
PATENT GRANTED
EP11736028

PYRAZOLO [1, 5A]PYRIMIDINE AND THIENO [3, 2B]PYRIMIDINE DERIVATIVES AS IRAK4 MODULATORS

IPC classification:
A61K 31/4365, A61K 31/519, A61P 11/00, A61P 29/00, C07D 487/04, C07D 495/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Julien Schirlin, F. Hoffmann-La Roche AG
Status:
GRANT OF PATENT INTENDED
EP11757296

AZABENZOTHIAZOLE COMPOUNDS, COMPOSITIONS AND METHODS OF USE

IPC classification:
A61K 31/429, A61P 29/00, C07D 513/00
Applicant:
F. Hoffmann-La Roche AG
Agent:
Julien Schirlin, F. Hoffmann-La Roche AG
Status:
GRANT OF PATENT INTENDED
EP11784634

METHODS OF TREATING TUMORS

IPC classification:
A61K 31/105, A61K 31/519, A61K 31/713, A61P 35/00
Applicant:
F. Hoffmann-La Roche AG
Agent:
Julien Schirlin, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP11807875

LIPOSOMAL FORMULATION OF DALCETRAPIB

IPC classification:
A61K 9/00, A61K 9/127, A61K 9/19, A61K 31/167, A61K 31/265, A61P 9/10
Applicant:
F. Hoffmann-La Roche AG
Agent:
Julien Schirlin, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED
EP11804528

PROCESS FOR THE PREPARATION OF AROMATIC THIOL DERIVATIVES BY HYDROGENATION OF DISULFIDES

IPC classification:
C07C 319/06, C07C 323/40, C07C 327/30, C07D 277/64
Applicant:
F. Hoffmann-La Roche AG
Agent:
Julien Schirlin, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP12710902

6,5-HETEROCYCLIC PROPARGYLIC ALCOHOL COMPOUNDS AND USES THEREFOR

IPC classification:
A61K 31/506, A61K 31/53, A61P 29/00, A61P 35/00, C07D 401/14, C07D 403/04, C07D 403/14, C07D 405/14, C07D 413/14, C07D 417/14, C07D 487/04, C07D 491/10
Applicant:
F. Hoffmann-La Roche AG
Agent:
Julien Schirlin, F. Hoffmann-La Roche AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12710724

THIAZOLOPYRIMIDINE COMPOUNDS

IPC classification:
A61K 31/519, A61P 19/02, C07D 513/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Julien Schirlin, F. Hoffmann-La Roche AG
Status:
PATENT GRANTED
EP12725741

BENZOCYCLOHEPTENE ACETIC ACIDS

IPC classification:
A61K 31/18, A61K 31/44, A61P 11/00, C07C 311/20, C07C 311/29, C07D 213/34, C07D 213/71
Applicant:
F. Hoffmann-La Roche AG
Agent:
Julien Schirlin, F. Hoffmann-La Roche AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12735129

METHOD FOR THE PREPARATION OF CYCLOHEXANECARBOXYLIC ACID

IPC classification:
C07C 51/06, C07C 51/08, C07C 61/08, C07C 319/06, C07C 319/20, C07C 327/30
Applicant:
F. Hoffmann-La Roche AG
Agent:
Julien Schirlin, F. Hoffmann-La Roche AG
Status:
GRANT OF PATENT INTENDED
EP12734923

AMINOMETHYL QUINOLONE COMPOUNDS

IPC classification:
A61K 31/4709, A61P 3/10, A61P 19/00, A61P 25/00, A61P 35/00, C07D 215/233, C07D 215/48, C07D 401/12, C07D 405/12, C07D 413/04, C07D 413/12, C07D 413/14, C07D 417/12, C07D 417/14
Applicant:
F. Hoffmann-La Roche AG
Agent:
Julien Schirlin, F. Hoffmann-La Roche AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12748670

PYRAZOLO[3,4-c]PYRIDINE COMPOUNDS AND METHODS OF USE

IPC classification:
A61K 31/437, A61P 9/00, A61P 35/00, A61P 37/00, C07D 471/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Julien Schirlin, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP12755816

SERINE/THREONINE PAK1 INHIBITORS

IPC classification:
A61K 31/506, A61P 35/00, C07D 403/14
Applicant:
F. Hoffmann-La Roche AG
Agent:
Julien Schirlin, F. Hoffmann-La Roche AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12766626

IMIDAZOPYRIDINE COMPOUNDS, COMPOSITIONS AND METHODS OF USE

IPC classification:
A61K 31/437, A61P 29/00, C07D 471/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Julien Schirlin, F. Hoffmann-La Roche AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12762606

PYRAZOL-4-YL-HETEROCYCLYL-CARBOXAMIDE COMPOUNDS AND METHODS OF USE

IPC classification:
A61K 31/427, A61K 31/4965, A61K 31/55, A61P 35/00, C07D 401/14, C07D 403/14, C07D 417/12, C07D 417/14, C07D 451/06, C07D 471/10, C07D 487/10, C07D 491/107, C07D 498/04, C07D 498/08, C07D 498/10
Applicant:
F. Hoffmann-La Roche AG
Agent:
Julien Schirlin, F. Hoffmann-La Roche AG
Status:
GRANT OF PATENT INTENDED
EP12761923

PYRROLOPYRAZINE KINASE INHIBITORS

IPC classification:
A61K 31/4985, A61K 31/5025, A61P 29/00, C07D 487/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Julien Schirlin, F. Hoffmann-La Roche AG
Status:
PATENT GRANTED
EP12783182

IMIDAZOPYRIDAZINE COMPOUNDS

IPC classification:
A61K 31/5025, A61P 3/10, A61P 11/06, A61P 17/06, A61P 19/02, A61P 25/28, A61P 29/00, A61P 35/00, A61P 35/02, A61P 37/00, C07D 487/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Julien Schirlin, F. Hoffmann-La Roche AG
Status:
GRANT OF PATENT INTENDED
EP12805511

PIPERIDINYL NAPHTHYLACETIC ACIDS

IPC classification:
A61K 31/451, A61P 11/00, A61P 11/06, A61P 11/08, C07D 211/18, C07D 211/96
Applicant:
F. Hoffmann-La Roche AG
Agent:
Julien Schirlin, F. Hoffmann-La Roche AG
Status:
PATENT GRANTED
EP12812254

2, 4-DIAMINE-PYRIMIDINE DERIVATIVE AS SERINE/THREONINE KINASE INHIBITORS

IPC classification:
A61K 31/4353, A61P 35/00, C07D 471/04, C07D 487/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Julien Schirlin, F. Hoffmann-La Roche AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13700132

PYRIDAZINE AMIDE COMPOUNDS AND THEIR USE AS SYK INHIBITORS

IPC classification:
A61K 31/50, A61K 31/501, A61P 11/06, A61P 29/00, A61P 37/00, C07D 237/24, C07D 401/12, C07D 401/14, C07D 403/12, C07D 405/14, C07D 471/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Julien Schirlin, F. Hoffmann-La Roche AG
Status:
PATENT GRANTED
EP13700133

THIENOPYRIMIDINE COMPOUNDS

IPC classification:
A61K 31/519, A61P 3/10, A61P 17/06, A61P 19/02, A61P 25/28, A61P 35/00, C07D 495/04, C07D 513/04, C07D 519/00
Applicant:
F. Hoffmann-La Roche AG
Agent:
Julien Schirlin, F. Hoffmann-La Roche AG
Status:
PATENT GRANTED
EP13704125

TRICYCLIC COMPOUNDS AND METHODS OF USE THEREFOR

IPC classification:
A61K 31/553, A61P 25/00, C07D 498/00, C07D 498/04, C07D 498/12
Applicant:
F. Hoffmann-La Roche AG
Agent:
Julien Schirlin, F. Hoffmann-La Roche AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12711669

ADAMANTYL COMPOUNDS

IPC classification:
C07D 215/48, C07D 401/04, C07D 413/04, C07D 471/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Julien Schirlin, F. Hoffmann-La Roche AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13708841

METHODS OF TREATING MELANOMA WITH PAK1 INHIBITORS

IPC classification:
A61K 31/41, A61P 35/00
Applicant:
F. Hoffmann-La Roche AG
Agent:
Julien Schirlin, F. Hoffmann-La Roche AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13719522

NEW FORMULATION

IPC classification:
A61K 9/20, A61K 9/24, A61K 31/167, A61K 31/265, A61K 31/40
Applicant:
F. Hoffmann-La Roche AG
Agent:
Julien Schirlin, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP13731771

5-AZAINDAZOLE COMPOUNDS AND METHODS OF USE

IPC classification:
A61K 31/437, A61P 3/00, A61P 5/00, A61P 25/00, A61P 35/00, C07D 471/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Julien Schirlin, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP13750700

PYRROLO[2,3-B]PYRAZINES AS SYK INHIBITORS

IPC classification:
A61K 31/4985, A61P 3/10, A61P 25/28, A61P 35/00, A61P 37/00, A61P 37/06, C07D 487/04, C07D 519/00
Applicant:
F. Hoffmann-La Roche AG
Agent:
Julien Schirlin, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP13770441

CYCLIC ETHER PYRAZOL-4-YL-HETEROCYCLYL-CARBOXAMIDE COMPOUNDS AND METHODS OF USE

IPC classification:
A61K 31/427, A61K 31/4375, A61K 31/4439, A61P 35/00, C07D 405/14, C07D 417/14, C07D 471/04, C07D 493/08
Applicant:
F. Hoffmann-La Roche AG
Agent:
Julien Schirlin, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP13783333

3,4-DISUBSTITUTED OXAZOLIDINONE DERIVATIVES AND THEIR USE AS INHIBITORS OF THE CALCIUM ACTIVATED POTASSIUM CHANNEL

IPC classification:
A61K 31/421, A61K 31/422, A61P 7/10, A61P 9/10, A61P 11/06, A61P 13/12, A61P 19/02, A61P 29/00, A61P 35/00, C07D 263/20, C07D 263/32, C07D 413/04, C07D 413/06
Applicant:
F. Hoffmann-La Roche AG
Agent:
Julien Schirlin, F. Hoffmann-La Roche AG
Status:
The patent has been granted
EP11700907

TRICYCLIC HETEROCYCLIC COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF

IPC classification:
A61K 31/437, A61P 11/06, A61P 17/06, A61P 19/02, A61P 37/00, A61P 37/06, C07D 471/14, C07D 487/10
Applicant:
F. Hoffmann-La Roche AG
Agent:
Julien Schirlin, F. Hoffmann-La Roche AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14714628

GENETIC MARKERS FOR PREDICTING RESPONSIVENESS TO THERAPY

IPC classification:
C12Q 1/68
Applicant:
F. Hoffmann-La Roche AG
Agent:
Julien Schirlin, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP11711062

PYRROLOPYRAZINE DERIVATIVES AND THEIR USE AS JAK AND SYK INHIBITORS

IPC classification:
A61K 31/4985, A61P 29/00, A61P 37/02, A61P 37/08, C07D 487/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Julien Schirlin, F. Hoffmann-La Roche AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11719576

PYRROLO [2, 3 - B]PYRAZINE - 7 - CARBOXAMIDE DERIVATIVES AND THEIR USE AS JAK AND SYK INHIBITORS

IPC classification:
A61K 31/4985, A61P 29/00, A61P 37/00, C07D 487/04, C07D 519/00
Applicant:
F. Hoffmann-La Roche AG
Agent:
Julien Schirlin, F. Hoffmann-La Roche AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14755806

ALKYNYL ALCOHOLS AND METHODS OF USE

IPC classification:
A61K 31/4155, A61K 31/416, C07D 401/10, C07D 401/14, C07D 403/10, C07D 403/14, C07D 413/10, C07D 413/14, C07D 417/10, C07D 471/04, C07D 487/04, C07D 491/048, C07D 491/052, C07D 495/04, C07D 513/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Julien Schirlin, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP14755363

ALKYNYL ALCOHOLS AND METHODS OF USE

IPC classification:
A61K 31/439, A61P 29/00, C07D 401/10, C07D 401/14, C07D 403/10, C07D 403/14, C07D 405/14, C07D 409/14, C07D 413/10, C07D 413/14, C07D 417/14, C07D 471/04, C07D 487/04, C07D 491/107, C07D 495/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Julien Schirlin, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP11721743

PYRROLOPYRAZINE DERIVATIVES AS SYK AND JAK INHIBITORS

IPC classification:
A61K 31/4965, A61K 31/497, A61P 3/00, A61P 9/00, A61P 11/00, A61P 19/00, A61P 25/00, A61P 29/00, A61P 35/00, A61P 37/00, C07D 487/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Julien Schirlin, F. Hoffmann-La Roche AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14842356

TRIAZOLOPYRIDINE COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF

IPC classification:
A61K 31/41, A61K 31/437, A61P 11/06, A61P 29/00, C07D 471/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Julien Schirlin, F. Hoffmann-La Roche AG
Status:
GRANT OF PATENT INTENDED
EP14761328

COMBINATION OF A MEK INHIBITOR AND AN ERK INHIBITOR FOR USE IN TREATMENT OF HYPERPROLIFERATIVE DISEASES

IPC classification:
A61K 31/435, A61K 31/437, A61K 31/5025, A61K 31/506, A61P 35/00
Applicant:
F. Hoffmann-La Roche AG
Agent:
Julien Schirlin, F. Hoffmann-La Roche AG
Status:
GRANT OF PATENT INTENDED
EP14786629

USE OF N-(4-TERT-BUTYLBENZYL)-3-CHLORO-N-[2-(4-CHLORO-3-ETHYL-PHENYL)-ETHYL]-2-FLUORO- 5-TRIFLUOROMETHYL-BENZAMIDE FOR THE TREATMENT OF EYE DISEASES

IPC classification:
A61K 31/166, A61K 45/06, A61P 27/02
Applicant:
F. Hoffmann-La Roche AG
Agent:
Julien Schirlin, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP11725032

INHIBITORS OF JNK

IPC classification:
A61K 31/4985, A61P 3/10, A61P 11/06, A61P 19/02, A61P 29/00, C07D 487/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Julien Schirlin, F. Hoffmann-La Roche AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11758183

PROCESS FOR PREPARING A CYCLOHEXANECARBONITRILE DERIVATIVE

IPC classification:
C07C 51/06, C07C 51/08, C07C 51/60, C07C 61/08, C07C 253/30, C07C 255/46, C07C 319/06, C07C 319/22, C07C 321/28, C07C 327/06
Applicant:
F. Hoffmann-La Roche AG
Agent:
Julien Schirlin, F. Hoffmann-La Roche AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11776201

A COMPOSITION COMPRISING S-[2-([[1-(2-ETHYLBUTYL)-CYCLOHEXYL]-CARBONYL]AMINO)PHENYL]2-METHYLPROPANETHIOATE AND CROSCARMELLOSE SODIUM

IPC classification:
A61K 9/20, A61K 31/265
Applicant:
F. Hoffmann-La Roche AG
Agent:
Julien Schirlin, F. Hoffmann-La Roche AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11723059

2-AMINO-PYRIMIDINE DERIVATIVES USEFUL AS INHIBITORS OF JNK

IPC classification:
A61K 31/506, A61P 3/10, A61P 11/06, A61P 19/02, A61P 29/00, C07D 401/04, C07D 401/14, C07D 403/04, C07D 403/14, C07D 409/14, C07D 487/02
Applicant:
F. Hoffmann-La Roche AG
Agent:
Julien Schirlin, F. Hoffmann-La Roche AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11790910

PYRAZOLOPYRIDINES AND THEIR USE AS TYK2 INHIBITORS

IPC classification:
A61K 31/37, A61K 31/519, A61P 11/02, A61P 11/06, A61P 17/06, A61P 19/02, C07D 471/04, C07D 487/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Julien Schirlin, F. Hoffmann-La Roche AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12706505

A PROCESS FOR CONTROLLED CRYSTALLIZATION OF AN ACTIVE PHARMACEUTICAL INGREDIENT FROM SUPERCOOLED LIQUID STATE BY HOT MELT EXTRUSION

IPC classification:
A61K 9/14
Applicant:
F. Hoffmann-La Roche AG
Agent:
Julien Schirlin, F. Hoffmann-La Roche AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14812502

CETP MODULATOR FOR USE IN THE TREATMENT OF EYE DISEASE

IPC classification:
A61K 31/167, A61P 27/02
Applicant:
F. Hoffmann-La Roche AG
Agent:
Julien Schirlin, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED
EP15710197

OXEPAN-2-YL-PYRAZOL-4-YL-HETEROCYCLYL-CARBOXAMIDE COMPOUNDS AND METHODS OF USE

IPC classification:
A61K 31/427, A61K 31/4439, A61K 31/4709, A61K 31/497, A61K 31/4985, A61P 35/00, C07D 417/14, C07D 487/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Julien Schirlin, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED
EP15726064

5-CHLORO-2-DIFLUOROMETHOXYPHENYL PYRAZOLOPYRIMIDINE COMPOUNDS WHICH ARE JAK INHIBITORS

IPC classification:
A61K 31/519, A61P 11/06, A61P 29/00, C07D 487/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Julien Schirlin, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED
EP15729520

IMIDAZO[1,2-A]PYRAZIN-1YL-BENZAMIDE COMPOUNDS FOR TREATING SPINAL MUSCULAR ATROPHY

IPC classification:
A61K 31/519, A61P 21/00, C07D 487/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Julien Schirlin, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED
EP15781941

BIOMARKERS AND METHODS OF PREDICTION

IPC classification:
G01N 33/68
Applicant:
F. Hoffmann-La Roche AG
Agent:
Julien Schirlin, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP15801747

BIOMARKERS OF FAST PROGRESSION OF CHRONIC KIDNEY DISEASE

IPC classification:
G01N 33/68
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Agent:
Julien Schirlin, F. Hoffmann-La Roche AG
Status:
Request for examination was made

Please Sign in to use this feature